Aprogen Medicines Inc. (KRX:007460)
South Korea
· Delayed Price · Currency is KRW 293.00
-24.00 (-7.57%)
Apr 15, 2026, 9:54 AM KST
Aprogen Medicines Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 45,148 | 37,162 | 35,684 | 43,070 | 15,894 | Upgrade
|
| Short-Term Investments | - | - | - | - | 4,000 | Upgrade
|
| Trading Asset Securities | 5,612 | 6,500 | 5,000 | 4,390 | - | Upgrade
|
| Cash & Short-Term Investments | 50,760 | 43,662 | 40,684 | 47,460 | 19,894 | Upgrade
|
| Cash Growth | 16.26% | 7.32% | -14.28% | 138.57% | -91.62% | Upgrade
|
| Accounts Receivable | 25,976 | 19,674 | 24,809 | 21,389 | 1,567 | Upgrade
|
| Other Receivables | 3,558 | 1,170 | 1,607 | 7,988 | 9,759 | Upgrade
|
| Receivables | 60,612 | 24,356 | 34,637 | 92,306 | 56,990 | Upgrade
|
| Inventory | 60,894 | 62,483 | 60,815 | 61,467 | 23,257 | Upgrade
|
| Prepaid Expenses | 1,179 | 967.42 | 847.35 | 913.48 | 906.58 | Upgrade
|
| Other Current Assets | 5,199 | 2,849 | 7,224 | 9,432 | 2,052 | Upgrade
|
| Total Current Assets | 178,643 | 134,317 | 144,207 | 211,578 | 103,099 | Upgrade
|
| Property, Plant & Equipment | 367,267 | 364,181 | 362,959 | 365,100 | 314,479 | Upgrade
|
| Long-Term Investments | 19,296 | 9,790 | 2,447 | 3,298 | 54,786 | Upgrade
|
| Goodwill | 50,958 | - | - | - | - | Upgrade
|
| Other Intangible Assets | 17,415 | 6,106 | 7,489 | 8,431 | 2,633 | Upgrade
|
| Long-Term Deferred Tax Assets | 2,683 | - | - | 662.84 | - | Upgrade
|
| Long-Term Deferred Charges | 54,420 | 46,601 | 34,625 | 4,988 | - | Upgrade
|
| Other Long-Term Assets | 22,788 | 3,902 | 1,224 | 5,222 | 1,904 | Upgrade
|
| Total Assets | 717,265 | 609,968 | 594,428 | 599,853 | 477,646 | Upgrade
|
| Accounts Payable | 5,014 | 3,423 | 2,734 | 4,186 | 3,920 | Upgrade
|
| Accrued Expenses | 4,445 | 2,683 | 2,556 | 4,117 | 8,410 | Upgrade
|
| Short-Term Debt | 101,114 | 35,784 | 46,631 | 49,763 | 398,613 | Upgrade
|
| Current Portion of Long-Term Debt | 45,000 | 45,000 | 44,938 | 7,675 | - | Upgrade
|
| Current Portion of Leases | 1,030 | 592.23 | 560.08 | 934.88 | 2,785 | Upgrade
|
| Current Income Taxes Payable | - | 246.72 | - | 4.18 | - | Upgrade
|
| Current Unearned Revenue | 234.25 | - | - | - | - | Upgrade
|
| Other Current Liabilities | 26,932 | 25,231 | 28,222 | 23,253 | 8,202 | Upgrade
|
| Total Current Liabilities | 183,769 | 112,959 | 125,640 | 89,933 | 421,929 | Upgrade
|
| Long-Term Debt | 40,000 | 32,000 | 32,000 | 31,251 | 31,046 | Upgrade
|
| Long-Term Leases | 718.46 | 326.69 | 288.35 | 571.03 | 19,925 | Upgrade
|
| Pension & Post-Retirement Benefits | 16,835 | 15,694 | 11,740 | 10,319 | 4,076 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 8,734 | 6,590 | 5,375 | 5,322 | 1,167 | Upgrade
|
| Other Long-Term Liabilities | 8,598 | 2,308 | 1,696 | 1,455 | 309.39 | Upgrade
|
| Total Liabilities | 258,655 | 169,878 | 176,740 | 138,851 | 478,453 | Upgrade
|
| Common Stock | 164,653 | 152,062 | 132,419 | 126,834 | 260,351 | Upgrade
|
| Additional Paid-In Capital | 521,069 | 512,886 | 472,949 | 431,641 | 46,794 | Upgrade
|
| Retained Earnings | -488,200 | -418,506 | -358,604 | -293,691 | -192,837 | Upgrade
|
| Treasury Stock | -98,115 | -98,115 | -98,115 | -98,084 | - | Upgrade
|
| Comprehensive Income & Other | 58,904 | 10,306 | -849.67 | 48,392 | -112,146 | Upgrade
|
| Total Common Equity | 158,310 | 158,634 | 147,800 | 215,092 | 2,163 | Upgrade
|
| Minority Interest | 300,300 | 281,457 | 269,888 | 245,910 | -2,970 | Upgrade
|
| Shareholders' Equity | 458,610 | 440,091 | 417,688 | 461,002 | -806.44 | Upgrade
|
| Total Liabilities & Equity | 717,265 | 609,968 | 594,428 | 599,853 | 477,646 | Upgrade
|
| Total Debt | 187,862 | 113,702 | 124,417 | 90,195 | 452,369 | Upgrade
|
| Net Cash (Debt) | -137,102 | -70,041 | -83,732 | -42,736 | -432,475 | Upgrade
|
| Net Cash Per Share | -6913.47 | -4070.09 | -5318.10 | -3167.42 | -37416.92 | Upgrade
|
| Filing Date Shares Outstanding | 20.54 | 18.89 | 16.27 | 15.53 | 4.43 | Upgrade
|
| Total Common Shares Outstanding | 20.54 | 18.89 | 16.27 | 15.53 | 4.43 | Upgrade
|
| Working Capital | -5,126 | 21,357 | 18,567 | 121,644 | -318,829 | Upgrade
|
| Book Value Per Share | 7708.38 | 8397.29 | 9083.11 | 13851.34 | 488.78 | Upgrade
|
| Tangible Book Value | 89,938 | 152,528 | 140,311 | 206,661 | -469.92 | Upgrade
|
| Tangible Book Value Per Share | 4379.21 | 8074.10 | 8622.88 | 13308.41 | -106.18 | Upgrade
|
| Land | 60,081 | 50,012 | 44,136 | 44,190 | 12,484 | Upgrade
|
| Buildings | 122,711 | 115,772 | 115,622 | 113,611 | 88,041 | Upgrade
|
| Machinery | 268,124 | 221,978 | 195,122 | 191,265 | 137,051 | Upgrade
|
| Construction In Progress | 29,566 | 61,140 | 107,580 | 88,234 | 85,017 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.